Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 9172726, 5 pages
http://dx.doi.org/10.1155/2016/9172726
Research Article

Influence of βS-Globin Haplotypes and Hydroxyurea on Arginase I Levels in Sickle Cell Disease

1Post-Graduate Program in Pathology, Federal University of Ceará, Rua Capitão Francisco Pedro, 1210 Rodolfo Teófilo, 60430-370 Fortaleza, CE, Brazil
2Post-Graduate Program in Development and Technological Innovation in Drugs, Federal University of Ceará, Rua Capitão Francisco Pedro, 1210 Rodolfo Teófilo, 60430-370 Fortaleza, CE, Brazil
3Department of Clinical and Toxicological Analysis, University of Ceará, Rua Capitão Francisco Pedro, 1210 Rodolfo Teófilo, 60430-370 Fortaleza, CE, Brazil
4Post-Graduate Program in Pharmaceutical Sciences, Federal University of Ceará, Rua Capitão Francisco Pedro, 1210 Rodolfo Teófilo, 60430-370 Fortaleza, CE, Brazil

Received 22 October 2015; Revised 17 February 2016; Accepted 24 February 2016

Academic Editor: Irene Rebelo

Copyright © 2016 J. A. Moreira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Barabino, M. O. Platt, and D. K. Kaul, “Sickle cell biomechanics,” Annual Review of Biomedical Engineering, vol. 12, pp. 345–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. H. F. Bunn, “Pathogenesis and treatment of sickle cell disease,” The New England Journal of Medicine, vol. 337, no. 11, pp. 762–769, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Vilas-Boas, B. A. V. Cerqueira, A. M. D. Zanette, M. G. Reis, M. Barral-Netto, and M. S. Goncalves, “Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients,” Annals of Hematology, vol. 89, no. 9, pp. 877–882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. J. Kato, R. P. Hebbel, M. H. Steinberg, and M. T. Gladwin, “Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions,” American Journal of Hematology, vol. 84, no. 9, pp. 618–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. R. Morris, M. T. Gladwin, and G. J. Kato, “Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders,” Current Molecular Medicine, vol. 8, no. 7, pp. 620–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. R. Powars, H. J. Meiselman, T. C. Fisher, A. Hiti, and C. Johnson, “Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia: use in predicting clinical severity,” American Journal of Pediatric Hematology/Oncology, vol. 16, no. 1, pp. 55–61, 1994. View at Google Scholar · View at Scopus
  7. A. Y. Elderdery, J. Mills, B. A. Mohamed et al., “Molecular analysis of the β-globin gene cluster haplotypes in a Sudanese population with sickle cell anaemia,” International Journal of Laboratory Hematology, vol. 34, no. 3, pp. 262–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. K. Ballas, “More definitions in sickle cell disease: steady state v base line data,” American Journal of Hematology, vol. 87, no. 3, p. 338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Sambrook, E. F. Fritsch, and T. Maniats, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 1989.
  10. R. K. Saiki, S. Scharf, F. Faloona et al., “Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia,” Science, vol. 230, no. 4732, pp. 1350–1354, 1985. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Sutton, E. E. Bouhassira, and R. L. Nagel, “Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes,” American Journal of Hematology, vol. 32, no. 1, pp. 66–69, 1989. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-J. B. Schnog, E. H. Jager, F. P. L. van der Dijs et al., “Evidence for a metabolic shift of arginine metabolism in sickle cell disease,” Annals of Hematology, vol. 83, no. 6, pp. 371–375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. D. Adekile, “What's new in the pathophysiology of sickle cell disease?” Medical Principles and Practice, vol. 22, no. 4, pp. 311–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Akinsheye, A. Alsultan, N. Solovieff et al., “Fetal hemoglobin in sickle cell anemia,” Blood, vol. 118, no. 1, pp. 19–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. E. W. Iyamu, R. Cecil, L. Parkin, G. Woods, K. Ohene-Frempong, and T. Asakura, “Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy,” British Journal of Haematology, vol. 131, no. 3, pp. 389–394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Steinberg, Z.-H. Lu, F. B. Barton, M. L. Terrin, S. Charache, and G. J. Dover, “Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea,” Blood, vol. 89, no. 3, pp. 1078–1088, 1997. View at Google Scholar · View at Scopus
  17. L. B. da Silva, R. P. Gonçalves, and S. H. B. Rabenhorst, “Análise dos haplótipos da anemia falciforme em Fortaleza revela as origens étnicas da população cearense,” Jornal Brasileiro de Patologia e Medicina Laboratorial, vol. 45, no. 2, pp. 115–118, 2009. View at Publisher · View at Google Scholar